
A recent conversation with Kevin Wilkinson, a professor of environmental chemistry at the Université de Montréal, sheds light on why no single signature can separate engineered nanoparticles from natural ones.
Renishaw’s RA802 Pharmaceutical Analyser was used to detect small amounts of different polymorphic forms of an active pharmaceutical ingredient in a generic drug powder.






